Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
2
FDA:2
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)A Comparison of Technegas and Xenon-133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy
Phase 3
Terminated
- Conditions
- Lung Structure Determination
- Interventions
- Drug: Xe-133Drug: Technegas
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2021-09-24
- Lead Sponsor
- Cyclomedica Australia PTY Limited
- Target Recruit Count
- 226
- Registration Number
- NCT03054870
- Locations
- 🇺🇸
Morton Plant Hospital, Clearwater, Florida, United States
🇺🇸Mayo Clinic in Jacksonville, FL, Jacksonville, Florida, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Compare Technegas Ventilation-Perfusion SPECT and Xenon Ventilation-Perfusion Planar Imaging for Pulmonary Embolism
Phase 3
Terminated
- Conditions
- Pulmonary Embolism
- Interventions
- Drug: Technegas V SPECT imaging
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2015-11-10
- Lead Sponsor
- Cyclomedica Australia PTY Limited
- Target Recruit Count
- 18
- Registration Number
- NCT01458639
- Locations
- 🇺🇸
Barnes-Jewish Hospital, Washington University, St. Louis, Missouri, United States
🇺🇸Columbia University Medical Center, New York, New York, United States
News
No news found